Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infectious Pneumonia and Lower Airway Microorganisms in Patients with Rheumatoid Arthritis.
Ideguchi S, Yamamoto K, Tahara M, Koga T, Ide S, Hirayama T, Takazono T, Imamura Y, Miyazaki T, Sakamoto N, Morimoto S, Izumikawa K, Yanagihara K, Ashizawa K, Aoki T, Kawakami A, Yatera K, Mukae H. Ideguchi S, et al. Among authors: morimoto s. J Clin Med. 2021 Aug 12;10(16):3552. doi: 10.3390/jcm10163552. J Clin Med. 2021. PMID: 34441847 Free PMC article.
The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT).
Haraguchi A, Shigeno R, Horie I, Morimoto S, Ito A, Chiba K, Kawazoe Y, Tashiro S, Miyamoto J, Sato S, Yamamoto H, Osaki M, Kawakami A, Abiru N. Haraguchi A, et al. Among authors: morimoto s. Trials. 2020 May 5;21(1):379. doi: 10.1186/s13063-020-04276-4. Trials. 2020. PMID: 32370806 Free PMC article.
Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan.
Endo Y, Kawashiri SY, Morimoto S, Nishino A, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Tada Y, Kawakami A. Endo Y, et al. Among authors: morimoto s. Immunol Med. 2020 Sep;43(3):115-120. doi: 10.1080/25785826.2020.1757920. Epub 2020 May 12. Immunol Med. 2020. PMID: 32393150 Free article.
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis.
Fukui S, Morimoto S, Ichinose K, Nakashima S, Ishimoto H, Hara A, Kakugawa T, Sakamoto N, Tsuji Y, Aramaki T, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Ueki Y, Suzuki S, Mukae H, Kawakami A. Fukui S, et al. Among authors: morimoto s. Sci Rep. 2020 Jun 11;10(1):9466. doi: 10.1038/s41598-020-66178-4. Sci Rep. 2020. PMID: 32528054 Free PMC article.
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Morimoto S, Minoda S, Kawazoe Y, Kuroda S, Tashiro S, Sumiyoshi R, Hosogaya N, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Aug 7;99(32):e21480. doi: 10.1097/MD.0000000000021480. Medicine (Baltimore). 2020. PMID: 32769882 Free PMC article.
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial.
Koga T, Hagimori N, Takemori S, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Jul 24;99(30):e20710. doi: 10.1097/MD.0000000000020710. Medicine (Baltimore). 2020. PMID: 32791665 Free PMC article.
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments.
Kawashiri SY, Shimizu T, Sato S, Morimoto S, Kawazoe Y, Sumiyoshi R, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Kawashiri SY, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Jul 24;99(30):e21151. doi: 10.1097/MD.0000000000021151. Medicine (Baltimore). 2020. PMID: 32791688 Free PMC article.
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Endo Y, Fukui S, Umekita K, Suzuki T, Miyamoto J, Morimoto S, Shimizu T, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Okada A, Fujikawa K, Mizokami A, Matsuoka N, Aramaki T, Ueki Y, Eguchi K, Kariya Y, Hashiba Y, Hidaka T, Okayama A, Kawakami A, Nakamura H. Endo Y, et al. Among authors: morimoto s. Mod Rheumatol. 2021 Sep;31(5):972-978. doi: 10.1080/14397595.2020.1847802. Epub 2020 Nov 27. Mod Rheumatol. 2021. PMID: 33161771
An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant).
Koga T, Takemori S, Hagimori N, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Dec 11;99(50):e23291. doi: 10.1097/MD.0000000000023291. Medicine (Baltimore). 2020. PMID: 33327255 Free PMC article.
2,118 results